Prevention of VZV infection in immunosuppressed patients using antiviral agents

Herpes

Volumn 13, Issue 3, 2006, Pages 60-65

  Boeckh, Michael ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b USA   (United States)

Author keywords

Aciclovir; Immunosuppressed patients; Post exposure prophylaxis; Reactivation; Varicella zoster virus

Indexed keywords

5 (2 BROMOVINYL) 2' DEOXYURIDINE; ACICLOVIR; CHICKENPOX VACCINE; CIDOFOVIR; FAMCICLOVIR; FOSCARNET; GANCICLOVIR; HERPES ZOSTER IMMUNOGLOBULIN; LIVE VACCINE; VALACICLOVIR; VIDARABINE;

ANTIVIRAL ACTIVITY; ARTICLE; AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION; CAREGIVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG ACTIVITY; DRUG EFFICACY; DRUG ERUPTION; DRUG MEGADOSE; DRUG SAFETY; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HERPES ZOSTER; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; LOW DRUG DOSE; MONOTHERAPY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; REBOUND; SIDE EFFECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT; VARICELLA ZOSTER VIRUS; VIRUS REACTIVATION; VIRUS SHEDDING;

ACYCLOVIR; ANTIVIRAL AGENTS; CHEMOPREVENTION; CHICKENPOX; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPES ZOSTER; HERPESVIRUS 3, HUMAN; HUMANS; IMMUNOCOMPROMISED HOST; VALINE; VIRUS ACTIVATION;

HUMAN HERPESVIRUS 3;

EID: 33845652183     PISSN: 09697667     EISSN: 14701537     Source Type: Journal    
DOI: None     Document Type: Article

References (62)

1. Arvin AM. Varicella-zoster virus: pathogenesis, immunity, and clinical management in hematopoietic cell transplant recipients. Biol Blood Marrow Transplant 2000;6:219-230.
2. Locksley RM, Flournoy N, Sullivan KM, Meyers JD. Infection with varicella-zoster virus after marrow transplantation. J Infect Dis 1985;152:1172-1181.
3. Koc Y, Miller KB, Schenkein DP, Griffith J, Akhtar M, DesJardin J et al. Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome. Biol Blood Marrow Transplant 2000;6:44-49.
4. Han CS, Miller W, Haake R, Weisdorf D. Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications. Bone Marrow Transplant 1994;13:277-283.
5. Crippa F, Holmberg L, Carter RA, Hooper H, Marr KA, Bensinger W et al. Infectious complications after autologous CD34-selected peripheral blood stem cell transplantation. Biol Blood Marrow Transplant 2002;8:281-289.
6. Leung TF, Chik KW, Li CK, Lai H, Shing MM, Chan PK et al. Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation. Bone Marrow Transplant 2000;25:167-172.
7. Tomonari A, Iseki T, Takahashi S, Ooi J, Takasugi K, Shimohakamada Y et al. Varicella-zoster virus infection in adult patients after unrelated cord blood transplantation: a single institute experience in Japan. Br J Haematol 2003;122:802-805.
8. Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA et al. Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation. Blood 2001;97:3380-3389.
9. Frere P, Baron F, Bonnet C, Hafraoui K, Pereira M, Evelyne W et al. Infections after allogeneic hematopoietic stem cell transplantation with a nonmyeloablative conditioning regimen. Bone Marrow Transplant 2006;37:411-418.
10. Gourishankar S, McDermid JC, Jhangri GS, Preiksaitis JK. Herpes zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era. Am J Transplant 2004;4:108-115.
11. Herrero JI, Quiroga J, Sangro B, Pardo F, Rotellar F, Alvarez-Cienfuegos J et al. Herpes zoster after liver transplantation: incidence, risk factors, and complications. Liver Transpl 2004;10:1140-1143.
12. Hardy I, Gershon AA, Steinberg SP, LaRussa P. The incidence of zoster after immunization with live attenuated varicella vaccine. A study in children with leukemia. Varicella Vaccine Collaborative Study Group. N Engl J Med 1991;325:1545-1550.
13. Floisand Y, Brinch L, Gedde-Dahl T, Tjonnfjord GE. Treatment of T-cell prolymphocytic leukemia with monoclonal anti-CD52 antibody (alemtuzumab). Tidsskr Nor Laegeforen 2004;124:768-770.
14. Hackanson B, Zeiser R, Bley TA, Pantazis G, Huzly D, Bertz H et al. Fatal varicella zoster virus encephalitis in two patients following allogeneic hematopoietic stem cell transplantation. Clin Transplant 2005;19:566-570.
15. Kalpoe JS, van Dehn CE, Bollemeijer JG, Vaessen N, Claas EC, Barge RM et al. Varicella zoster virus (VZV)-related progressive outer retinal necrosis (PORN) after allogeneic stem cell transplantation. Bone Marrow Transplant 2005;36:467-469.
16. Walton RC, Reed KL. Herpes zoster ophthalmicus following bone marrow transplantation in children. Bone Marrow Transplant 1999;23:1317-1320.
17. Au WY, Hon C, Cheng VC, Ma ES. Concomitant zoster myelitis and cerebral leukemia relapse after stem cell transplantation. Ann Hematol 2005;84:59-60.
18. Meyers JD, Wade JC, Shepp DH, Newton B. Acyclovir treatment of varicella-zoster virus infection in the compromised host. Transplantation 1984;37:571-574.
19. Whitley RJ, Gnann JW, Jr, Hinthorn D, Liu C, Pollard RB, Hayden F et al. Disseminated herpes zoster in the immunocompromised host: a comparative trial of acyclovir and vidarabine. The NIAID Collaborative Antiviral Study Group J Infect Dis 1992;165:450-455.
20. Berman JN, Wang M, Berry W, Neuberg DS, Guinan EC. Herpes zoster infection in the post-hematopoietic stem cell transplant pediatric population may be preceded by transaminitis: an institutional experience. Bone Marrow Transplant 2006;37:73-80.
21. Morishita K, Kodo H, Asano S, Fujii H, Miwa S. Fulminant varicella hepatitis following bone marrow transplantation. JAMA 1985;253:511.
22. Schiller GJ, Nimer SD, Gajewski JL, Golde DW. Abdominal presentation of varicella-zoster infection in recipients of allogeneic bone marrow transplantation. Bone Marrow Transplant 1991;7:489-491.
23. Perez-Oteyza J, Pascual C, Garcia-Larana J, Odriozola J. Rocamora A, Navarro JL. Abdominal presentation of varicella zoster infection after bone marrow transplantation. Bone Marrow Transplant 1992;9:217.
24. Stemmer SM. Kinsman K. Tellschow S, Jones RB. Fatal noncutaneous visceral infection with varicella-zoster virus in a patient with lymphoma after autologous bone marrow transplantation. Clin Infect Dis 1993;16:497-499.
25. Verdonck LF, Cornelissen JJ, Dekker AW, Rozenberg-Arska M. Acute abdominal pain as a presenting symptom of varicella-zoster virus infection in recipients of bone marrow transplants. Clin Infect Dis 1993;16:190-191.
26. McCluggage WG, Fox JD, Baillie KE, Coyle PV, Jones FG, O'Hara MD. Varicella zoster gastritis in a bone marrow transplant recipient. J Clin Pathol 1994;47:1054-1056.
27. Rogers SY. Irving W, Harris A, Russell NH. Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant 1995;15:805-807.
28. David DS, Tegtmeier BR, O'Donnell MR, Paz IB, McCarty TM. Visceral varicella-zoster after bone marrow transplantation: report of a case series and review of the literature. Am J Gastroenterol 1998;93:810-813.
29. Yagi T, Karasuno T, Hasegawa T, Yasumi M, Kawamoto S, Murakami M et al. Acute abdomen without cutaneous signs of varicella zoster virus infection as a late complication of allogeneic bone marrow transplantation: importance of empiric therapy with acyclovir. Bone Marrow Transplant 2000;25:1003-1005.
30. Itoh M, Kawaguchi S, Yago K, Shimada H, Muro H. Acute abdominal pain preceding cutaneous manifestations of varicella zoster infection after allogeneic bone marrow transplantation. Tohoku J Exp Med 2001;195:61-63.
31. Grant RM, Weitzman SS, Sherman CG, Sirkin WL, Petric M, Tellier R. Fulminant disseminated varicella zoster virus infection without skin involvement. J Clin Virol 2002;24:7-12.
32. Hyland JM, Butterworth J. Severe acute visceral pain from varicella zoster virus. Anesth Analg 2003;97:1117-1118.
33. Takatoku M, Muroi K, Kawano-Yamamoto C, Nagai T, Komatsu N, Ozawa K. involvement of the esophagus and stomach as a first manifestation of varicella zoster virus infection after allogeneic hone marrow transplantation. Intern Med 2004;43:861-864.
34. Ljungman P, Wilczek H, Gahrton G, Gustavsson A, Lundgren G, Lonnqvist B et al. Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro. Bone Marrow Transplant 1986;1:185-192.
35. Vazquez M, LaRussa PS, Gershon AA. Steinberg SP. Freudigman K, Shapiro ED. The effectiveness of the varicella vaccine in clinical practice. N Engl J Med 2001;344:955-960.
36. Centers for Disease Control and Prevention, the American Society of Blood and Marrow Transplantation and the Infectious Disease Society of America. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Biol Blood Marrow Transplant 2000;6:659-713.
37. Snoeck R. Andrei G, De Clercq E. Current pharmacological approaches to the therapy of varicella zoster virus infections: a guide to treatment. Drugs 1999;57:187-206.
38. Boeckh M, Gooley TA, Myerson D, Cunningham T, Schoch G, Bowden RA. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study. Blood 1996;88:4063-4071.
39. Selby PJ, Powles RL, Easton D, Perren TJ, Stolle K, Jameson B et al. The prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantation. Br J Cancer 1989;59:434-438.
40. Sempere A, Sanz GF, Senent L, de la Rubia J, Jarque I, Lopez F et al. Long-term acyclovir prophylaxis for prevention of varicella zoster virus infection after autologous blood stem cell transplantation in patients with acute leukemia. Bone Marrow Transplant 1992;10:495-498.
41. Prentice HG, Gluckman E, Powles RL, Ljungman P, Milpied N, Fernandez Ranada JM et al. Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 1994;343:749-753.
42. Steer CB, Szer J, Sasadeusz J, Matthews JP, Beresford JA, Grigg A. Varicella-zoster infection after allogeneic bone marrow transplantation: incidence, risk factors and prevention with low-dose aciclovir and ganciclovir. Bone Marrow Transplant 2000;25:657-664.
43. Kanda Y, Mineishi S, Saito T. Saito A, Yamada S. Ohnishi M et al. Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic: hematopoietic stem cell transplantation. Bone Marrow Transplant 2001;28:689-692.
44. Thomson KJ, Hart DP, Banerjee L, Ward KN, Peggs KS, Mackinnon S. The effect of low-dose aciclovir on reactivation of varicella zoster virus after allogeneic haemopoietic stem cell transplantation. Bone Marrow Transplant 2005;35:1065-1069.
45. Boeckh M, Kim HW, Flowers ME, Meyers JD, Bowden RA. Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation - a randomized double-blind placebo-controlled study. Blood 2006;107:1800-1805.
46. Erard V, Wald A, Leisenring W, Varley C, Heugel C, Corey L et al. Long term suppressive acyclovir (ACV) reduces VZV disease and ACV-resistant HSV after hematopoietic cell transplantation. Biol Blood Marrow Transplant 2006;12:140-141.
47. Weinstock DM, Boeckh M, Boulad F, Eagan JA. Fraser VJ, Henderson DK et al. Postexposure prophylaxis against varicella-zoster virus infection among recipients of hematopoietic stem cell transplant: unresolved issues. Infect Control Hosp Epidemiol 2004;25:603-608.
48. Levin MJ, Nelson WL, Preblud SR. Clinical Trials with Varicella Zoster Virus Immunoglobulins. London: Academic Press, 1986.
49. Goldstein SL, Somers MJ, Lande MB, Brewer ED, Jabs KL. Acyclovir prophylaxis of varicella in children with renal disease receiving steroids. Pediatr Nephrol 2000;14:305-308.
50. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T et al. Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 1993;92:219-222.
51. Yoshikawa T, Suga S, Kozawa T, Kawaguchi S, Asano Y. Persistence of protective immunity after postexposure prophylaxis of varicella with oral aciclovir in the family setting. Arch Dis Child 1998;78:61-63.
52. Suga S, Yoshikawa T, Ozaki T, Asano Y. Effect of oral acyclovir against primary and secondary viraemia in incubation period of varicella. Arch Dis Child 1993;69:639-642; discussion 642-633.
53. Weinstock DM, Boeckh M, Sepkowitz KA. Post-exposure prophylaxis against VZV infection among hematopoietic stem cell transplant recipients (letter). Biol Blood Marrow Transplant 2006;12:1096-1097.
54. Asanuma H, Sharp M, Maecker HT, Maino VC, Arvin AM. Frequencies of memory T-cells specific for varicella-zoster virus, herpes simplex virus, and cytomegalovirus by intracellular detection of cytokine expression. J Infect Dis 2000;181:859-866.
55. Hata A, Asanuma H, Rinki M, Sharp M, Wong RM, Blume K et al. Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. N Engl J Med 2002;347:26-34.
56. Sauerbrei A, Prager J, Hengst U, Zintl F, Wutzler P. Varicella vaccination in children after bone marrow transplantation. Bone Marrow Transplant 1997;20:381-383.
57. Weinberg A, Horslen SP, Kaufman SS, Jesser R, Devoll-Zabrocki A, Fleckten BL et al. Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant 2006;6:565-568.
58. Levin MJ, Gershon AA, Weinberg A, Blanchard S, Nowak B, Palumbo P et al. Immunization of HIV-infected children with varicella vaccine. J Pediatr 2001;139:305-310.
59. Levin MJ, Gershon AA, Weinberg A, Song LY, Fentin T, Nowak B. Administration of live varicella vaccine to HIV-infected children with current or past significant depression of CD4+ T cells. J Infect Dis 2006;194:247-255.
60. Patel SR, Ortin M. Varicella-zoster reactivation in a patient receiving routine revaccinations after an allogeneic hemopoietic progenitors transplant. J Pediatr Hematol Oncol 2005;27:106-108.
61. Galil K, Lee B, Strine T, Carraher C, Baughman AL, Eaton M et al. Outbreak of varicella at a day-care center despite vaccination. N Engl J Med 2002;347:1909-1915.
62. Fiddian P. Sabin CA, Griffiths PD. Valacyclovir provides optimum acyclovir exposure for prevention of cytomegalovirus and related outcomes after organ transplantation. J Infect Dis 2002;186(Suppl 1): S110-S115.